Age: 21.0
Sex: M
Vaccine: HPV4
Symptoms: Fear, Feeling abnormal, Gait disturbance, Hypoaesthesia, Inappropriate schedule of product administration
Clinical narrative: as well as a constellation of adverse symptoms; depression; droopiness in his left eyelid; decline in ability to speak coherently/speech impediment; Autoimmune Disease/heterogenous autoimmune disease; Autonomic Dysfunction/autonomic/Dysautonomia; Postural orthostatic tachycardia syndrome; On 30-JUN-2016 and 12-JUL-2017, the pateint was vaccinetd with GARDASIL; Information had been received regarding a case in litigation from a lawyer and referred to a 22 years old male patient (pt). Prior to receiving his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections, the pt was healthy and had no autoimmune diseases, and no autonomic issues. On 30-JUN-2016, the pt's health care provider recommended that he received the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine, which was stated as a safe and effective vaccine for preventing human papillomavirus (HPV) cancer. On the same day, the pt received his first dosage of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis. On 12-JUL-2017, the pt received the third vaccination of the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) series for prophylaxis (Inappropriate schedule of vaccine administered). The dose, strength, route, lot number and expiration date were unknown for suspect vaccine. On 16-AUG-2017 (reported as thirty-five days after vaccination), the pt developed symptoms that ultimately included pain and discomfort in most of his joints. He developed weakness, numbness, tingling, and stiffness in his face and extremities, including his hands, feet and toes. He also developed muscle spasms and twitching throughout his body, speech impediment, and short-term memory decline. As the months progressed, so did the pt's injuries. He was seen by multiple physicians and specialists for his complaints which now included: muscle spasms, soreness and stiffness when he walked, chronic neck pain, whole body pain, fatigue and lethargy, severe brain fog, debilitating dizziness and lightheadedness, droopiness in his left eyelid, decline in ability to speak coherently, shortness of breath, stress and depression. As a result of his post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was unable to engage in normal activities that a normal young person would enjoy. Based upon his chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt had been diagnosed with various medical conditions, including but not limited to, Postural orthostatic tachycardia syndrome (POTS). The pt contended that his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused him to develop serious and debilitating injuries, including but not limited to autonomic, neurological, heterogenous autoimmune disease, POTS, and dysautonomia, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt had suffered and continues to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. The pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his autoimmune disease and other injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he would continue to incur these losses and expenses in the future. The outcome of the events (except for Inappropriate schedule of vaccine administered) was considered as not recovered. The causality assessment between the suspect vaccine and the events was related (except for Inappropriate schedule of vaccine administered).   Upon internal review, the autoimmune disorder as determined to be medically significant.  The reporter considered the events (except for Inappropriate schedule of vaccine administered) to be disability.